This paper is in the following e-collection/theme issue:

HIV/AIDS/STI Prevention and Care (882) Prevention and Health Promotion (1015) Pharmacology and Pharmaceutics (70)

Published on in Vol 9 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/50894, first published .
Pretreatment HIV Drug Resistance and the Molecular Transmission Network Among HIV-Positive Individuals in China in 2022: Multicenter Observational Study

Pretreatment HIV Drug Resistance and the Molecular Transmission Network Among HIV-Positive Individuals in China in 2022: Multicenter Observational Study

Pretreatment HIV Drug Resistance and the Molecular Transmission Network Among HIV-Positive Individuals in China in 2022: Multicenter Observational Study

Authors of this article:

Hongli Chen1, 2 Author Orcid Image ;   Jingjing Hao1 Author Orcid Image ;   Jing Hu1 Author Orcid Image ;   Chang Song1 Author Orcid Image ;   Yesheng Zhou1 Author Orcid Image ;   Miaomiao Li1 Author Orcid Image ;   Jin Chen1 Author Orcid Image ;   Xiu Liu1 Author Orcid Image ;   Dong Wang1 Author Orcid Image ;   Xiaoshan Xu1 Author Orcid Image ;   Peixian Xin1 Author Orcid Image ;   Jiaxin Zhang1 Author Orcid Image ;   Lingjie Liao1 Author Orcid Image ;   Yi Feng1 Author Orcid Image ;   Dan Li1 Author Orcid Image ;   Stephen W Pan3 Author Orcid Image ;   Yiming Shao1 Author Orcid Image ;   Yuhua Ruan1 Author Orcid Image ;   Hui Xing1 Author Orcid Image
Article Authors Cited by Tweetations (2) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.